Rite Aid (RAD) – Press Releases
-
Carenet Health Acquiring Health Dialog, Enhancing Clinical Team and Advancing Insights-Driven Platform Dedicated to the Business of Healthcare
-
Rite Aid Receives Court Approval of "First Day" Motions to Support Business Operations
-
Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success
-
Rite Aid Takes Steps to Accelerate Transformation and Position Company for Long-Term Success
-
Rite Aid Corporation Appoints Jeffrey S. Stein Chief Executive Officer
-
CORRECTING and REPLACING Creep It Simple: Rite Aid Releases DIY Halloween Costume Recipe Cards
-
Creep It Simple: Rite Aid Releases DIY Halloween Costume Recipe Cards
-
RAD receives approval for Phase 1 therapeutic study of PDL1-nanobody in Non-Small Cell Lung Cancer
-
Rite Aid Helps Families Prep for Fall the Rite Way with Family Immunization Day
-
Rite Aid Announces Receipt of Notice of Non-Compliance with NYSE Continued Listing Standards
-
Rite Aid Invites Customers to ‘Live flavorably!™’ with Launch of Ello Market
-
Rite Aid and Bartell Drugs Announce Availability of Appointments for Updated COVID-19 Vaccine
-
Rite Aid Announces Availability of OTC NARCAN® Nasal Spray at All Locations
-
Radiopharm Theranostics Expands Supply Agreement With TerThera for Terbium-161 Isotope Use in Prostate Cancer
-
Rite Aid Announces Availability of Flu and RSV Vaccine Appointments at All Locations
-
Rite Aid Shares Progress on Environmental, Social and Governance Efforts in Fifth Annual Report
-
Rite Aid Offering Back to School Family Immunization Days
-
Rite Aid Corporation Reports Fiscal 2024 First Quarter Results
-
Rite Aid to Release First Quarter Results on June 29
-
Rite Aid Names Thomas Sabatino Chief Legal Officer
-
Rite Aid Empowers Customers to Be Themselves with Launch of RYSHI™ Beauty and Personal Care Essentials
-
Elixir announces the next wave of innovation for pharmacy benefits technology platform
-
RITE AID CORPORATION (NYSE: RAD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against R
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against United Natural Foods, Tupperware, and Rite Aid and Encourages Investors to Contact the Firm
-
Radiopharm Theranostics Receives FDA Orphan Drug Designation for Trivehexin (RAD 301) in Pancreatic Cancer
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tupperware, Rite Aid, and Dish and Encourages Investors to Contact the Firm
-
ROSEN, LEADING TRIAL ATTORNEYS, Encourages Rite Aid Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – RAD
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tupperware, Rite Aid, and Dish and Encourages Investors to Contact the Firm
-
RITE AID CORPORATION (NYSE: RAD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against R
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against United Natural Foods, Tupperware, and Rite Aid and Encourages Investors to Contact the Firm
-
Rite Aid Looks to ‘Ease the Sneeze’ This Allergy Season
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tupperware, Rite Aid, and Dish and Encourages Investors to Contact the Firm
-
RAD LOSS ALERT: ROSEN, A LEADING INVESTOR RIGHTS LAW FIRM, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – RAD
-
Rite Aid Corporation Reports Fiscal 2023 Fourth Quarter and Full Year Results and Provides Fiscal 2024 Outlook
-
ROSEN, TRUSTED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors with Losses to Secure Counsel Before Important Deadline in Securities Class Action Filed by the Firm – RAD
-
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Tupperware, Rite Aid, Dish, and Stanley and Encourages Investors to Contact the Firm
-
Radiopharm Theranostics Enters Into Supply Agreement with TerThera for Terbium-161 Isotope
-
RITE AID CORPORATION (NYSE: RAD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against R
-
RITE AID CORPORATION (NYSE: RAD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Reminds Investors of the Deadline to File a Lead Plaintiff Motion in a Securities Class Action Lawsuit Against R
-
ROSEN, GLOBALLY RESPECTED INVESTOR COUNSEL, Encourages Rite Aid Corporation Investors to Secure Counsel Before Important Deadline in Securities Class Action Commenced by the Firm – RAD
-
Radiopharm Theranostics Invited to Participate in Jefferies Radiopharma Innovation Summit
-
RITE AID CORPORATION (NYSE: RAD) SHAREHOLDER CLASS ACTION ALERT: Bernstein Liebhard LLP Announces that a Securities Class Action Lawsuit Has Been Filed Against Rite Aid Corporation (NYSE: RAD)
-
Rite Aid to Release Fourth Quarter Results on April 20
-
Radiopharm Theranostics Partners With Next Generation Preclinical Platform for Therapeutic Radiopharmaceuticals
-
Dr Ken Herrmann Appointed to RAD Scientific Advisory Board
-
Radiopharm Theranostics Initiates Process for Nasdaq Listing
-
Rite Aid Corporation Names Elizabeth “Busy” Burr Interim Chief Executive Officer
-
Rite Aid Corporation Reports Fiscal 2023 Third Quarter Results
-
RITE AID DEADLINE ALERT: Bragar Eagel & Squire, P.C. Reminds Investors that a Class Action Lawsuit Has Been Filed Against Rite Aid Corporation and Encourages Investors to Contact the Firm
-
Shareholder Alert: Lowey Dannenberg Reminds Rite Aid Corporation (NYSE: RAD) Investors of Securities Class Action Lawsuit and Upcoming Lead Plaintiff Deadline
Back to RAD Stock Lookup
